CAROLYN FOWLER SIDOR
Medical Practice in Chapel Hill, NC
License number
Pennsylvania MD033503E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Chapel Hill, NC 27517
Pennsylvania
Pennsylvania
Personal information
See more information about CAROLYN FOWLER SIDOR at radaris.comName
Address
Phone
81414 Alexander, Chapel Hill, NC 27514
100 Lancaster Ave, Wynnewood, PA 19096
300 Lancaster Ave, Wynnewood, PA 19096
300 E Lancaster Ave #100, Wynnewood, PA 19096
Professional information
Dr. Carolyn F Sidor, Chapel Hill NC - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
101 Manning Dr, Chapel Hill 27514
(919) 966-4996 (Phone), (919) 843-5515 (Fax)
81414 Alexander, Chapel Hill 27517
(919) 932-2666 (Phone), (919) 960-7647 (Fax)
(919) 966-4996 (Phone), (919) 843-5515 (Fax)
81414 Alexander, Chapel Hill 27517
(919) 932-2666 (Phone), (919) 960-7647 (Fax)
Certifications:
Hematology, 1988, Internal Medicine, 1985, Medical Oncology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
101 Manning Dr, Chapel Hill 27514
81414 Alexander, Chapel Hill 27517
University of North Carolina Hospital
101 Manning Dr, Chapel Hill 27514
81414 Alexander, Chapel Hill 27517
University of North Carolina Hospital
101 Manning Dr, Chapel Hill 27514
Education:
Medical School
Thomas Jefferson University
Graduated: 1982
Med Ctr Delaware
Main Line Hospital-Lankenau
Thomas Jefferson University
Graduated: 1982
Med Ctr Delaware
Main Line Hospital-Lankenau
Carolyn Sidor, Chapel Hill NC
Work:
Unc Physicans And Associates
6013 Farrington Rd, Chapel Hill, NC 27517
6013 Farrington Rd, Chapel Hill, NC 27517
Method Of Administering Anti-Angiogenic Agents And A Method Of Treating Disease Using Same
US Patent:
2006011, Jun 1, 2006
Filed:
Nov 29, 2005
Appl. No.:
11/288989
Inventors:
William Fogler - Rockville MD, US
Carolyn Sidor - Chapel Hill NC, US
Anthony Treston - Rockville MD, US
Kirk Volker - North Potomac MD, US
Carolyn Sidor - Chapel Hill NC, US
Anthony Treston - Rockville MD, US
Kirk Volker - North Potomac MD, US
International Classification:
A61K 31/56
US Classification:
514182000
Abstract:
A method of administering an anti-angiogenic agent to a human or an animal comprising administering the anti-angiogenic agent such that a plasma concentration of the anti-angiogenic agent in the human or animal is substantially continuously maintained above 1 ng/mL.
Anti-Angiogenic Activity Of 2-Methoxyestradiol In Combination With Anti-Cancer Agents
US Patent:
2007018, Aug 9, 2007
Filed:
Nov 14, 2006
Appl. No.:
11/599997
Inventors:
Stacy Plum - Arlington VA, US
Steven Strawn - Arlington VA, US
Theresa LaVallee - Rockville MD, US
Carolyn Sidor - Chapel Hill NC, US
William Fogler - Rockville MD, US
Anthony Treston - Rockville MD, US
Steven Strawn - Arlington VA, US
Theresa LaVallee - Rockville MD, US
Carolyn Sidor - Chapel Hill NC, US
William Fogler - Rockville MD, US
Anthony Treston - Rockville MD, US
International Classification:
A61K 31/56
US Classification:
514182000, 514506000
Abstract:
The present invention relates generally to methods and compositions of treating disease characterized by abnormal cell proliferation and/or abnormal or undesirable angiogenesis by administering antiangiogenic agents in combination with chemotherapeutic agents. More specifically, the present invention relates to a methods and compositions of treating diseases characterized by abnormal cell proliferation and/or abnormal or undesirable angiogenesis by administering 2-methoxyestradiol, in combination with chemotherapeutic agents.
Disease Modifying Anti-Arthritic Activity Of 2-Methoxyestradiol
US Patent:
2007023, Oct 4, 2007
Filed:
Mar 20, 2007
Appl. No.:
11/726361
Inventors:
William Fogler - Rockville MD, US
Stacy Plum - Arlington VA, US
Carolyn Sidor - Chapel Hill NC, US
Stacy Plum - Arlington VA, US
Carolyn Sidor - Chapel Hill NC, US
International Classification:
A61K 33/24, A61K 31/66, A61K 31/616, A61K 31/56, A61K 31/525, A61K 31/519, A61K 31/59, A61K 31/192, A61K 31/415, A61K 31/365
US Classification:
424649000, 514182000, 514171000, 514251000, 514406000, 514471000, 514159000, 514165000, 514102000, 514570000, 514569000, 514109000, 514262100, 514546000, 514167000
Abstract:
The present invention relates a composition for treating rheumatic diseases. The composition comprises a compound having the formula
wherein Ris selected from —OCH, —OCHCH, —CH, —CHCH, —CCCH, —CHCH—CH, or CH—CHCH; and one or more anti-rheumatic agents. A method of using the composition for treating rheumatic diseases in humans and animals is also disclosed.
Anti-Angiogenic Activity Of 2-Methoxyestradiol Analogs In Combination With Anti-Cancer Agents
US Patent:
2010011, May 6, 2010
Filed:
Oct 31, 2008
Appl. No.:
12/262318
Inventors:
THERESA LAVALLEE - Rockville MD, US
WILLIAM E. FOGLER - Rockville MD, US
CAROLYN F. SIDOR - Chapel Hill NC, US
WILLIAM E. FOGLER - Rockville MD, US
CAROLYN F. SIDOR - Chapel Hill NC, US
International Classification:
A61K 31/565, A61P 35/00
US Classification:
514171
Abstract:
The present invention relates generally to methods and compositions for treating diseases characterized by abnormal cell proliferation and/or abnormal or undesirable angiogenesis by administering antiangiogenic agents in combination with anti-cancer agents. More specifically, the present invention relates to methods and compositions for treating diseases characterized by abnormal cell proliferation and/or abnormal or undesirable angiogenesis by administering 2-methoxyestradiol analogs, in combination with anti-cancer agents.